Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion The deal would give the pharmaceutical giant access to Alpine s potential treatment for chronic kidney disease.
.
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion The deal would give the pharmaceutical giant access to Alpine s potential treatment for chronic kidney disease.
.
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion The deal would give the pharmaceutical giant access to Alpine s potential treatment for chronic kidney disease.
.
Publicis Flags Tech Rebound as Revenue Growth Beats Expectations Publicis reported a 5.3% rise in first-quarter revenue, helped by new business wins and what it called a clear rebound in the.
Publicis Flags Tech Rebound as Revenue Growth Beats Expectations Publicis reported a 5.3% rise in first-quarter revenue, helped by new business wins and what it called a clear rebound in the.